586 related articles for article (PubMed ID: 18441725)
21. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation.
Bedaiwy MA; Forman R; Mousa NA; Al Inany HG; Casper RF
Hum Reprod; 2006 Nov; 21(11):2838-44. PubMed ID: 16877370
[TBL] [Abstract][Full Text] [Related]
22. Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination.
Mitwally MF; Abdel-Razeq S; Casper RF
Reprod Biol Endocrinol; 2004 Jul; 2():55. PubMed ID: 15239837
[TBL] [Abstract][Full Text] [Related]
23. Superovulation and intrauterine insemination vs. superovulation alone in the treatment of unexplained infertility. A randomized study.
Arcaini L; Bianchi S; Baglioni A; Marchini M; Tozzi L; Fedele L
J Reprod Med; 1996 Aug; 41(8):614-8. PubMed ID: 8866392
[TBL] [Abstract][Full Text] [Related]
24. [Controlled hyperstimulation in intra-uterine inseminations: hMG-hCG protocol (204 cycles)].
Abboud P; Delépine B; Pigeon F; Bednarczyk L; Quéreux C
Contracept Fertil Sex; 1997 Jun; 25(6):463-9. PubMed ID: 9280551
[TBL] [Abstract][Full Text] [Related]
25. Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination.
Duffy DA; Manzi D; Benadiva C; Maier D; Saunders M; Nulsen J
Fertil Steril; 2006 Feb; 85(2):407-11. PubMed ID: 16595219
[TBL] [Abstract][Full Text] [Related]
26. Two-day IUI treatment cycles are more successful than one-day IUI cycles when using frozen-thawed donor sperm.
Matilsky M; Geslevich Y; Ben-Ami M; Ben-Shlomo I; Weiner-Megnagi T; Shalev E
J Androl; 1998; 19(5):603-7. PubMed ID: 9796621
[TBL] [Abstract][Full Text] [Related]
27. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.
Dankert T; Kremer JA; Cohlen BJ; Hamilton CJ; Pasker-de Jong PC; Straatman H; van Dop PA
Hum Reprod; 2007 Mar; 22(3):792-7. PubMed ID: 17110396
[TBL] [Abstract][Full Text] [Related]
28. Clomiphene citrate monitoring for intrauterine insemination timing: a randomized trial.
Lewis V; Queenan J; Hoeger K; Stevens J; Guzick DS
Fertil Steril; 2006 Feb; 85(2):401-6. PubMed ID: 16595218
[TBL] [Abstract][Full Text] [Related]
29. A novel, simplified and cost effective protocol for superovulation and intrauterine insemination.
Williams RS; Kipersztok S; Hills D; Dattilo M
J Fla Med Assoc; 1997; 84(5):316-9. PubMed ID: 9260436
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors for pregnancy after intrauterine insemination (IUI): an analysis of 1038 cycles and a review of the literature.
Merviel P; Heraud MH; Grenier N; Lourdel E; Sanguinet P; Copin H
Fertil Steril; 2010 Jan; 93(1):79-88. PubMed ID: 18996517
[TBL] [Abstract][Full Text] [Related]
31. A randomized and longitudinal study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertility.
Nulsen JC; Walsh S; Dumez S; Metzger DA
Obstet Gynecol; 1993 Nov; 82(5):780-6. PubMed ID: 8414326
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of results of intrauterine insemination performed once or twice per stimulated cycle].
Ruiz Anguas J; Anta Jaen E; Durán Monterrosas L; Kably Ambe A
Ginecol Obstet Mex; 2005 Feb; 73(2):76-82. PubMed ID: 21961341
[TBL] [Abstract][Full Text] [Related]
33. The prevalence and influence of luteinizing hormone surges in stimulated cycles combined with intrauterine insemination during a prospective cohort study.
Cantineau AE; Cohlen BJ;
Fertil Steril; 2007 Jul; 88(1):107-12. PubMed ID: 17445811
[TBL] [Abstract][Full Text] [Related]
34. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
[TBL] [Abstract][Full Text] [Related]
35. Clomiphene citrate and intrauterine insemination: analysis of more than 4100 cycles.
Dovey S; Sneeringer RM; Penzias AS
Fertil Steril; 2008 Dec; 90(6):2281-6. PubMed ID: 18191842
[TBL] [Abstract][Full Text] [Related]
36. Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility.
Rashidi M; Aaleyasin A; Aghahosseini M; Loloi S; Kokab A; Najmi Z
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):244-7. PubMed ID: 23541417
[TBL] [Abstract][Full Text] [Related]
37. Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination.
Kabli N; Sylvestre C; Tulandi T; Buckett W
Fertil Steril; 2009 Apr; 91(4):1141-4. PubMed ID: 18342857
[TBL] [Abstract][Full Text] [Related]
38. Oral ovulation induction agents combined with low-dose gonadotropin injections and intrauterine insemination: cost- and clinical effectiveness.
Ryan GL; Moss V; Davis WA; Sparks AE; Dokras A; Van Voorhis BJ
J Reprod Med; 2005 Dec; 50(12):943-50. PubMed ID: 16444896
[TBL] [Abstract][Full Text] [Related]
39. Prospective, randomized, crossover study to evaluate the benefit of human chorionic gonadotropin-timed versus urinary luteinizing hormone-timed intrauterine inseminations in clomiphene citrate-stimulated treatment cycles.
Zreik TG; García-Velasco JA; Habboosh MS; Olive DL; Arici A
Fertil Steril; 1999 Jun; 71(6):1070-4. PubMed ID: 10360912
[TBL] [Abstract][Full Text] [Related]
40. Dexamethasone in unexplained infertility.
Moradan S; Ghorbani R
Saudi Med J; 2009 Aug; 30(8):1034-6. PubMed ID: 19668883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
